Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

publishing date : 2021 - 10 - 11    symbols : NVSEF    save search

Sandoz completes acquisition of GSK’s cephalosporin business, reinforcing leading global position in antibiotics
Published: 2021-10-11 (Crawled : 08:00) - globenewswire.com
NVSEF | News | $95.11 490 twitter stocktwits trandingview |
Health Technology
| | O: -0.72% H: 0.0% C: 0.0%
NVS | News | $97.25 2.24% 2.6M twitter stocktwits trandingview |
Health Technology
| | O: 0.16% H: 0.19% C: -0.64%

acquisition antibiotics iot positive
Gainers vs Losers
86% 14%

Top 10 Gainers
MTTR | News M | $4.56 162.07% 21M twitter stocktwits trandingview |

AGBA | $2.74 119.2% 52M twitter stocktwits trandingview |
Finance

CZOO | $9.07 81.76% 22M twitter stocktwits trandingview |

EDBL | News | $6.56 74.47% 1.8M twitter stocktwits trandingview |

MTC | $2.21 41.67% 5.6M twitter stocktwits trandingview |
Technology Services

OPRT | News | $3.12 38.67% 11M twitter stocktwits trandingview |
Finance

PALI | $6.59 33.67% 23M twitter stocktwits trandingview |
Manufacturing

VNRX | $0.7989 33.15% 3.2M twitter stocktwits trandingview |
Health Technology

BTCM | $3.51 30.0% 730K twitter stocktwits trandingview |
Arts, Entertainment, and Recrea...

MLEC | $1.81 29.29% 2.8M twitter stocktwits trandingview |
n/a


Your saved searches
Save your searches and get alerts when important news are released.